Clinical Trial Update: A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study of TAK-788 in adults with non-small cell lung cancer, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• TAK-788

Snippet

Sponsor: Takeda | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING